APOA1 and metabolic dysfunction-associated steatotic liver disease: In addition, proteomic pathway analyses highlighted other proteins involved in lipoprotein metabolism (APOA1, BMP1, FABP3 and ANGPTL4) that are key markers in obesity and NAFLD (e.g., [38,39]).